Your browser doesn't support javascript.
loading
Quantification of [18F]afatinib using PET/CT in NSCLC patients: a feasibility study.
van de Stadt, E A; Yaqub, M; Lammertsma, A A; Poot, A J; Schober, P R; Schuit, R C; Smit, E F; Bahce, I; Hendrikse, N H.
Affiliation
  • van de Stadt EA; Department of Pulmonology, Amsterdam UMC location VUmc, Amsterdam, the Netherlands. e.vandestadt@amsterdamumc.nl.
  • Yaqub M; Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands. e.vandestadt@amsterdamumc.nl.
  • Lammertsma AA; Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.
  • Poot AJ; Department of Radiology and Nuclear Medicine, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.
  • Schober PR; Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.
  • Schuit RC; Department of Radiology and Nuclear Medicine, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.
  • Smit EF; Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.
  • Bahce I; Department of Radiology and Nuclear Medicine, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.
  • Hendrikse NH; Department of Anesthesiology, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.
EJNMMI Res ; 10(1): 97, 2020 Aug 17.
Article in En | MEDLINE | ID: mdl-32804306
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: EJNMMI Res Year: 2020 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: EJNMMI Res Year: 2020 Document type: Article